Western Sydney Diabetes has rolled out a mobile diabetes management application from Taiwan as part of its patient engagement digitisation.
A centre led by the Western Sydney Local Health District (WSLHD), WSD has established an automated patient engagement programme with Health2Sync. It features the Health2Sync app which provides personalised lifestyle suggestions on managing blood sugar levels...
Digital health firm ConnectedHealth has unveiled a new disease management app targeting patients with type 2 diabetes mellitus and sub-optimal to poor blood glucose control.
WHAT IT DOES
On Wednesday, the company launched SugoSure, a subscription-based service that provides digital health support, doctor remote monitoring, and health coaching.
It features interfaces for three user types: a...
Taiwan-based diabetes management app Health2Sync announced that combining Fitbit wearable devices with their Health2Sync Patient Management Platform can help users control and better manage the symptoms of Type 2 diabetes mellitus (T2DM), based on the results from their clinical study in Taiwan.
WHAT’S IT ABOUT
The study, conducted with four of Taiwan's leading diabetes clinics, yielded some key...
WellDoc's BlueStar chronic disease-management tool has picked up another 510(k) FDA clearance that will allow it to support adult Type 2 diabetes patients using long-acting basal insulin. The feature was announced by WellDoc this morning, but cleared by the agency in April, according to a listing on its website.
The new capability takes the form of a new program within the prescription BlueStar...
Welldoc is tapping Astellas Pharma to assist Japanese and Asian commercialization efforts for the former’s digital therapeutic for patients with diabetes, the companies announced yesterday.
To kick off the deal, Astellas is making an upfront $15 million payment to Welldoc, which will allow the pharma to jointly develop and commercialize the BlueStar product in the region. The two will also be...
Type 1 diabetes management and CGM integration are now on the table for WellDoc’s BlueStar, a management platform well known for being the first mobile health product to secure reimbursement as a diabetes therapy.
Thanks to a new FDA clearance, the company’s seventh, BlueStar will include integrated glucose level insights related to food, medication and activity that are based on the data from...
Sugar.IQ — the digital diabetes assistant for Guardian Connect system users that is jointly supported by Medtronic and IBM Watson — has a new feature that uses artificial intelligence to predict future low glucose events.
Called IQcast, the feature tells users whether they have a low, medium or high chance of dropping below the target blood glucose range within the next one to four hours. These...
Ascensia Diabetes Care’s Contour Diabetes app — a mobile tool to monitor trends in blood glucose levels that connects to the Contour Next One glucometer — has received yet another update. As of Monday, iPhone users can transfer blood glucose and carbohydrate data from their app to records kept within the Apple Health platform.
After opting in, data collected through Ascensia’s app will...
Apple’s healthcare patent update. A new Hong Kong and European trademark updates the classification of Apple’s AirPods to include health, fitness, exercise and wellness sensors (kudos to Patently Apple, which spotted the update). The updated classification also includes language concerning the transmission of biometric data, heart rate, body movement and burned calories.
Despite this and other...
This morning digital diabetes coaching platform Fit4D landed another $4 million in funding. The round was led by SJF Ventures, C&B Capital, Esther Dyson, and North Haven Capital, with participation from Blue Cross and Blue Shield of Nebraska and StarUP Health.
The New York City-based startup plans to use the money to continue clinical validation and development of its product.
“We have...
